Miyoko Higuchi

Miyoko Higuchi

Auto-generated profile, based on publicly available information

Miyoko Higuchi

Department of Diagnostic Pathology and Cytology, Kuma Hospital, Kobe, Japan

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2019 in World Journal of Surgery
Verified
Journal Article
Open access
PDF file
THToshitetsu Hayashi
Toshitetsu Hayashi
MHMitsuyoshi Hirokawa
Mitsuyoshi Hirokawa
MHMiyoko Higuchi
Miyoko Higuchi
TKTakumi Kudo
Takumi Kudo
YIYasuhiro Ito
Yasuhiro Ito
AMAkira Miyauchi
Akira Miyauchi
Background: Needle tract implantation (NTI) can occur after thyroid fine‐needle aspiration cytology (FNAC). To date, no studies enrolling a large number of patients and studying the cumulative incidence (CI) of NTI have been published. This study analyzed the clinicopathological features of NTI and calculated the CI.Methods: A total of 11,745 patients who underwent first FNAC, resection for thyroid carcinomas and related lymph node metastases, and postoperative ultrasonography in Kuma Hospital between 2006 and 2017 were evaluated. NTI was defined as macroscopically visible and/or sonographically detected recurrent tumors at the sites of the previous aspiration. Lymphovascular invasion and/or nodal metastasis were excluded.Results: We found 22 NTI‐THY (originated from aspiration of thyroid tumors) and 8 NTI‐LN (originating from lymph nodes) cases with CI of 0.15% and 0.37%, and 0.37% and 0.58% at 5 and 10 years after FNAC, respectively. A large percentage (53%) of cases are presented as more aggressive histologic subtypes than their original tumors. Of these NTI patients, 4 (12.1%) died of disease and 10 (33.3%) developed distant metastases but remained alive with stable disease, three (9.1%) developed local recurrences, and the remaining 15 (10%) were free of recurrence.Conclusions: We demonstrated for the first time the CI and detailed clinicopathological features of thyroid NTI associated with possible histological transformation. Despite the low CI, the risk of death and distant metastases increase manifold in NTI patients than that in patients without recurrence. Therefore, NTI could be an important prognostic variable and impact patient survival.

1 January 2016 in Endocrine Journal
Verified
Journal Article
Open access
NTNami Takada
Nami Takada
MHMitsuyoshi Hirokawa
Mitsuyoshi Hirokawa
ASAyana Suzuki
Ayana Suzuki
MHMiyoko Higuchi
Miyoko Higuchi
SKSeiji Kuma
Seiji Kuma
AMAkira Miyauchi
Akira Miyauchi
Parathyroid and thyroid lesions appear morphologically similar in cytological smears, and their differentiation can be difficult. The purpose of this study was to determine the diagnostic value of T-cell-specific transcription factor GATA-3 as a marker of parathyroid differentiation in cytology specimens, and to examine the utility of liquid-based cytology (LBC). Cytology smears obtained from surgically removed parathyroid and thyroid specimens, including 15 normal parathyroid glands, 12 cases of parathyroid hyperplasia, 55 parathyroid adenomas, 2 follicular thyroid adenomas, and 3 papillary thyroid carcinomas, were examined by immunocytochemistry using antibodies against GATA-3, parathyroid hormone (PTH), chromogranin A, and thyroid transcription factor 1 (TTF-1). All normal and hyperplastic parathyroids and 98.2% of parathyroid adenomas were positive for GATA-3, while 33.3%, 66.7%, and 60.0% of them, respectively, were positive for PTH. The positive rates for chromogranin A among normal parathyroids (80.0%) and parathyroid adenomas (87.3%) were lower than those for GATA-3. At the same time, all thyroid-derived tumours were positive for TTF-1 and negative for GATA-3, PTH, and chromogranin A. LBC smears of 35 parathyroid lesions indicated that the positive rates for GATA-3, PTH, and chromogranin A were 97.1 %, 97.1%, and 100%, respectively, while in conventional smears, those for PTH (25.5%) and chromogranin A (78.7%) were significantly lower (p < 0.01). Our results suggest that GATA-3 is a more reliable biomarker than PTH or chromogranin A in differentiating parathyroid from thyroid lesions in cytology smears and that LBC is useful in detecting cytoplasmic antigens such as PTH and chromogranin A.

19 March 2021 in Pathology International
Verified
Journal Article
Open access
PDF file
MHMitsuyoshi Hirokawa
Mitsuyoshi Hirokawa
ASAyana Suzuki
Ayana Suzuki
MHMiyoko Higuchi
Miyoko Higuchi
THToshitetsu Hayashi
Toshitetsu Hayashi
SKSeiji Kuma
Seiji Kuma
AMAkira Miyauchi
Akira Miyauchi
This study aimed to clarify the histological alterations following fine‐needle aspiration for parathyroid adenoma and discuss the occurrence of diagnostic problems. Among the 392 patients with parathyroid adenoma who underwent resection, fine‐needle aspiration was performed for 21 (5.1%) parathyroid adenoma nodules. Histological findings that were significantly more frequent in cases that underwent fine‐needle aspiration were considered histological alterations following fine‐needle aspiration for parathyroid adenoma, including the following six findings: thick fibrous capsule (71.4%), multilayered fibrous capsules (14.3%), capsular pseudo‐invasion (42.9%), fibrous bands (57.1%), hemosiderin deposition (14.3%), and tumor implantation (14.3%). Eighteen parathyroid adenoma nodules (85.7%) exhibited one or more of the six findings. Tumor cells and adipocytes entrapped within the thick fibrous capsule were occasionally observed. The fibrous bands were frequently connected to the thick fibrous capsule. The number of passes, duration between fine‐needle aspiration and resection, tumor size, and purpose of fine‐needle aspiration were not related to the incidence of histological findings. Because of the histological alterations following fine‐needle aspiration for parathyroid adenoma that can be easily mistaken for signs of atypical adenoma or parathyroid carcinoma, we recommend that the six findings be excluded from pathological findings indicating atypical adenoma or parathyroid carcinoma in patients with preoperative fine‐needle aspiration.

13 November 2016 in Cytopathology
Verified
Journal Article
Open access
PDF file
MHM. Higuchi
M. Higuchi
MHMitsuyoshi Hirokawa
Mitsuyoshi Hirokawa
ASA. Suzuki
A. Suzuki
NTN. Takada
N. Takada
NYN. Yamao
N. Yamao
AMA. Miyauchi
A. Miyauchi
Objective: Solid variants of papillary thyroid carcinoma (SV‐PTC) are rare, and there have been few reports describing the cytological findings of such variants.Methods: The cytological features of cellular specimens aspirated from 18 histologically confirmed SV‐PTC cases were evaluated, retrospectively.Results: Solid and small papillary clusters were observed in 14 (77.8%) and 13 (72.2%) cases, respectively. The incidences of large papillary clusters (11.1%) and sheet‐like arrangements (11.1%) were low. Nuclear features were consistent with conventional PTC. The background was clean, and there were no colloid materials, foamy histiocytes, multinucleated giant cells, psammoma bodies, or necrotic materials.Conclusions: Solid clusters and small papillary clusters in conjunction with a clean background are diagnostic clues that indicate SV‐PTC cytologically. It is thought that small papillary clusters reflect the micropapillary growth pattern seen within the lumen of middle‐sized follicular structures. The presence of nuclear findings typical of conventional PTC and the absence of mitotic figures and necrotic materials are important for distinguishing SV‐PTC from poorly differentiated carcinoma.

1 January 2018 in Endocrine Journal
Verified
Journal Article
Open access
PDF file
MHMiyoko Higuchi
Miyoko Higuchi
MHMitsuyoshi Hirokawa
Mitsuyoshi Hirokawa
RKRisa Kanematsu
Risa Kanematsu
ATAki Tanaka
Aki Tanaka
ASAyana Suzuki
Ayana Suzuki
AMAkira Miyauchi
Akira Miyauchi
The Bethesda System for Reporting Thyroid Cytopathology has recently been revised in 2017 (TBSRTC 2017). This study aimed to evaluate the impact of modifying the diagnostic criteria in TBSRTC 2017 at a single institute. We retrospectively reviewed cytological specimens of 10,399 thyroid nodules submitted for thyroid fine-needle aspiration cytology. Among them, 56 atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS) nodules, 16 suspicious for malignancy (SFM) nodules, and 8 malignant nodules were re-categorized into follicular neoplasm or suspicious for a follicular neoplasm (FN/SFN). The incidence of FN/SFN was increased by 0.8%, while that of AUS/FLUS, SFM, and malignant nodule was decreased by 0.5%, 0.2%, and 0.1%, respectively. In nine (60%) of the 15 nodules that were re-classified from AUS/FLUS to FN/SFN nodules and re-aspiration was performed, it was possible to judge whether they were benign or malignant. Of the 24 patients with FN/SFN nodules originally diagnosed with SFM or malignant, 16 were followed up without surgical resection. In conclusion, TBSRTC 2017 only caused minor changes in the incidence of each diagnostic category. TBSRTC 2017 was revised to avoid false positives owing to noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) that account for >10% of papillary thyroid carcinomas; however, it is not necessary in low frequency NIFTP institutes or countries. In Japan, we propose active surveillance as an accepted option for clinically managing AUS/FLUS, FN/SFN, SFM, or malignant nodules having favorable benign clinical findings or being part of the low-risk group.

8 July 2021 in Pathobiology
Verified
Journal Article
Closed access
PDF file
RKRisa Kanematsu
Risa Kanematsu
MHMitsuyoshi Hirokawa
Mitsuyoshi Hirokawa
ATAki Tanaka
Aki Tanaka
ASAyana Suzuki
Ayana Suzuki
MHMiyoko Higuchi
Miyoko Higuchi
AMAkira Miyauchi
Akira Miyauchi
Introduction: An immunohistochemical study has occasionally been performed to diagnose anaplastic thyroid carcinoma (ATC). However, antibodies to confirm the undifferentiated nature of ATC have not yet been evaluated. The aim of this study was to evaluate E-cadherin and β-catenin expressions in immunoreactivity to determine undifferentiated carcinoma cells in the diagnosis of ATC. Methods: We immunohistochemically examined 29 ATCs, 30 poorly differentiated thyroid carcinomas (PDTCs), 22 well-differentiated thyroid carcinomas (WDTCs), and 3 squamous cell carcinomas. Antibodies for thyroid transcription factor-1 (TTF-1), paired-box gene 8 (PAX8), β-catenin, and E-cadherin were used. Results: All WDTCs tested positive for TTF-1, PAX8, and E-cadherin. The positive rates of TTF-1, PAX8, and E-cadherin were 93.3, 93.3, and 100%, respectively, in PDTCs and 17.2, 51.7, and 10.3%, respectively, in ATCs. WDTC expressed the lateral cell membrane staining for β-catenin and E-cadherin, whereas PDTC showed circumferential cell membranous expression (fishnet pattern). β-catenin cell membrane expression in ATCs is lost or discontinuous. Carcinoma cells with β-catenin nuclear expression without cell membranous expression were scattered in 72.4% of ATCs but were not observed in the other carcinomas. Conclusion: We propose 3 immunohistochemical findings to determine undifferentiated carcinoma cells in the diagnosis of ATC: (1) β-catenin nuclear expression with no or reduced cell membranous expression, (2) the loss or discontinuous pattern of E-cadherin expression, and (3) the loss of PAX8 nuclear expression.